1. [Home](https://www.g2.com/)
2. ...
3. [AWS Marketplace Software](https://www.g2.com/categories/aws-marketplace)
4. [Patient Eligibility for Cancer Trials Discussions](https://www.g2.com/products/patient-eligibility-for-cancer-trials/discuss)

[
 ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/large_detail/large_detail_80156f2e50fff64360d0ba3befe34052/patient-eligibility-for-cancer-trials.jpg "Product Avatar Image")
](/products/patient-eligibility-for-cancer-trials/reviews)

[

Patient Eligibility for Cancer Trials

](/products/patient-eligibility-for-cancer-trials/reviews)

0 ratings

The "Patient Eligibility for Cancer Trials" solution, available on AWS Marketplace, is designed to streamline the process of matching cancer patients with appropriate clinical trials. By leveraging advanced artificial intelligence and machine learning technologies, this solution automates the pre-screening process, significantly reducing the time and effort required by clinicians to identify suitable trials for their patients. Key Features and Functionality: - Automated Pre-Screening: Utilizes AI to analyze patient medical records and match them against clinical trial eligibility criteria, enhancing efficiency and accuracy. - Integration with Clinical Trial Databases: Connects seamlessly with existing clinical trial registries to access up-to-date information on available trials. - Customizable Matching Parameters: Allows for the adjustment of matching criteria to align with specific patient needs and trial requirements. - User-Friendly Interface: Provides an intuitive dashboard for clinicians to review and manage potential trial matches. Primary Value and Problem Solved: This solution addresses the challenges clinicians face in identifying and enrolling patients in suitable cancer clinical trials. By automating the pre-screening process, it reduces the time required to match patients with trials by approximately 40%, as demonstrated in real-life clinical trial matching tasks. This efficiency not only accelerates patient access to potentially life-saving treatments but also enhances the overall effectiveness of clinical research by facilitating the enrollment of eligible participants.

Show More

When users leave Patient Eligibility for Cancer Trials reviews, G2 also collects common questions about the day-to-day use of Patient Eligibility for Cancer Trials. These questions are then answered by our community of 850k professionals. Submit your question below and join in on the G2 Discussion.

* * *

### 0.0

Nps Score

### All Patient Eligibility for Cancer Trials Discussions

Search

Most CommentedMost HelpfulPinned by G2Newest

All DiscussionsDiscussions with CommentsPinned by G2Discussions without Comments

FilterFilter

Filter byExpand/Collapse 

Sort by

Most Commented

Most Helpful

Pinned by G2

Newest

Filter by

All Discussions

Discussions with Comments

Pinned by G2

Discussions without Comments

Sorry...

There are no questions about Patient Eligibility for Cancer Trials yet.

## Start a New Software Discussion

Have a software question?

Get answers from real users and experts

[Start A Discussion](/products/patient-eligibility-for-cancer-trials/discussions/new)

* * *

 ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/thumb_square/thumb_square_80156f2e50fff64360d0ba3befe34052/patient-eligibility-for-cancer-trials.jpg "Product Avatar Image")

### Have you used Patient Eligibility for Cancer Trials before?

Answer a few questions to help the Patient Eligibility for Cancer Trials community

[
Yes
](javascript:void(0))[
Yes
](https://www.g2.com/authorize?form=signup&return_to=https%3A%2F%2Fwww.g2.com%2Fproducts%2Fpatient-eligibility-for-cancer-trials%2Fdiscuss%3Fsmall_ask%3Dpatient-eligibility-for-cancer-trials)
No